Islet Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-603,813
Closed -$11.2M 292
2021
Q3
$11.2M Buy
+603,813
New +$12.2M 0.24% 113

Other funds holding OCDX

Islet Management's OCDX Position: Q4 2021 in Review

Islet Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q4 2021, closing a stake of 603,813 shares — an estimated $11.2M sold.

Islet Management first reported a position in OCDX in Q3 2021 and held it in 1 quarter. The position peaked at $11.2M in Q3 2021. 162 funds tracked by Wall St. Rank hold OCDX as of Q4 2021.

  • Islet Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Islet Management sold 603,813 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q4 2021, an estimated $11.2M.
  • Islet Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q3 2021 and held it in 1 quarter.
  • Islet Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $11.2M in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q4 2021.

Based on Islet Management's 13F filing for Q4 2021, filed 14 Feb 2022.